The clonoSEQ® Watch Registry
Public ClinicalTrials.gov record NCT04545333. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, multicenter, observational study of adult patients with a diagnosis of acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), or non-Hodgkin lymphoma (NHL). This study will enroll up to 528 patients in up to 50 sites in the United States and collect data with regard to use of the clonoSEQ MRD assay in the management of lymphoid malignancies.
Study identification
- NCT ID
- NCT04545333
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 465 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 13, 2020 (Actual)
- Primary completion
- Oct 1, 2023 (Actual)
- Completion
- Oct 1, 2023 (Actual)
- Last update posted
- Aug 1, 2024
2020 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Hospital | Stanford | California | 94305 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| Holy Cross Hospital | Fort Lauderdale | Florida | 33308 | — |
| Edward H. Kaplan MD & Associates | Skokie | Illinois | 60076 | — |
| Hematology Oncology Clinic | Baton Rouge | Louisiana | 70809 | — |
| American Oncology Partners of Maryland | Bethesda | Maryland | 20817 | — |
| Washington University | St Louis | Missouri | 63130 | — |
| Novant Health | Charlotte | North Carolina | 28204 | — |
| Oregon Health & Science University, Knight Cancer Institute | Portland | Oregon | 97239 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Bon Secours St Francis | Greenville | South Carolina | 29607 | — |
| University of Washington, Seattle Cancer Care Alliance | Seattle | Washington | 98102 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04545333, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04545333 live on ClinicalTrials.gov.